The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMan Regulatory News (EMG)

Share Price Information for Man (EMG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 250.20
Bid: 249.80
Ask: 250.20
Change: -4.40 (-1.73%)
Spread: 0.40 (0.16%)
Open: 255.40
High: 255.40
Low: 249.60
Prev. Close: 254.60
EMG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

19 Oct 2022 07:00

RNS Number : 3210D
Man Group plc
19 October 2022
 

Directorate Change

19 October 2022

Man Group plc (the "Company") announces the appointment of Alberto Musalem as a non-executive director of the Company and as a member of the Audit & Risk Committee and Remuneration Committee with effect from 1 November 2022.

John Cryan, Chair of Man Group, said:  "I am delighted to welcome Alberto to the Man Group Board. He brings extensive investment management experience, economic and public policy expertise and broad knowledge of capital markets and regulation. I am confident that Alberto will add significant value to Man Group and we look forward to working with him."

Alberto Musalem - previous experience

Alberto served as CEO and Co-CIO of Evince Asset Management LP (2018 - 2022), an investment manager which he co-founded. Prior to this, he served as Executive Vice President and Senior Advisor to the President at the Federal Reserve Bank of New York (2014 - 2017) where he led the Integrated Policy Analysis and the Emerging Markets and International Affairs Groups, and served on the Bank's Management Committee. Alberto held senior positions at Tudor Investment Corporation (2000 - 2013), including Managing Director, Partner, Global Head of Research, and member of the firm's Management Committee. He also served as an economist at the International Monetary Fund (1996 - 2000). 

Alberto is currently a director of Freddie Mac, a US federal home loan mortgage corporation founded by Congress, where he is a member of the Risk Committee, Operations and Technology Committee and Compensation and Human Capital Committee. He is a member of the Distinguished Advisory Group of the Integrity Council for the Voluntary Carbon Market, the Council on Foreign Relations, and the Economic Club of New York. He is also Adjunct Professor of Finance at Georgetown University's McDonough School of Business.

This announcement is made in compliance with the Company's obligations under Listing Rule 9.6.11R.

The Company confirms that no other disclosures are required pursuant to Listing Rule 9.6.13R.

 

Enquiries

Man Group

Communications

Georgiana Brunner

+44 20 7144 1000

media@man.com

 

Investor Relations

Karan Shirgaokar

+44 20 7144 1434

investor.relations@man.com

 

Company Secretary

Elizabeth Woods

+44 20 7144 1733

company.secretarial@man.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUWONRUNURAAA
Date   Source Headline
1st Sep 20217:00 amRNSTotal Voting Rights
31st Aug 20216:02 pmRNSTransaction in Own Shares
31st Aug 20217:47 amGNWMan Group PLC : Form 8.3 - Bally's Corporation
31st Aug 20217:22 amGNWMan Group PLC : Form 8.3 - Stonebridge Biopharma plc
30th Aug 20217:22 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
27th Aug 20215:41 pmRNSTransaction in Own Shares
27th Aug 20218:20 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
26th Aug 20215:35 pmRNSTransaction in Own Shares
26th Aug 202110:18 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
25th Aug 20215:47 pmRNSTransaction in Own Shares
25th Aug 202112:59 pmGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
25th Aug 202112:54 pmGNWMan Group PLC : Form 8.3 - Bally's Corporation
24th Aug 20215:45 pmRNSTransaction in Own Shares
24th Aug 202112:21 pmGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
24th Aug 202112:17 pmGNWMan Group PLC : Form 8.3 - Bally's Corporation
23rd Aug 20216:24 pmRNSTransaction in Own Shares
23rd Aug 20211:49 pmGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
23rd Aug 20211:47 pmGNWMan Group PLC : Form 8.3 - Bally's Corporation
20th Aug 20215:53 pmRNSTransaction in Own Shares
20th Aug 20218:57 amGNWMan Group PLC : Form 8.3 - Bally's Corporation
20th Aug 20218:56 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
19th Aug 20215:55 pmRNSTransaction in Own Shares
19th Aug 202112:27 pmGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
19th Aug 202112:23 pmGNWMan Group PLC : Form 8.3 - Vectura Group plc
19th Aug 20219:00 amRNSInterim Dividend Conversion Rate
18th Aug 20215:25 pmRNSTransaction in Own Shares
18th Aug 20218:24 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
17th Aug 20216:03 pmRNSTransaction in Own Shares
17th Aug 202110:24 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
16th Aug 20215:59 pmRNSTransaction in Own Shares
16th Aug 202112:05 pmGNWMan Group PLC : Form 8.3 - Strongbridge biopharma plc
13th Aug 20215:20 pmRNSTransaction in Own Shares
13th Aug 202111:05 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
12th Aug 20215:57 pmRNSTransaction in Own Shares
12th Aug 202111:23 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
11th Aug 20215:45 pmRNSTransaction in Own Shares
11th Aug 202110:36 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
11th Aug 20217:00 amRNSTransaction in Own Shares
10th Aug 202111:59 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
10th Aug 20217:00 amRNSShare buyback programme of up to $100 million
9th Aug 20219:41 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
9th Aug 20219:39 amGNWMan Group PLC : Form 8.3 - Bally's Corporation
6th Aug 20219:59 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
5th Aug 202110:30 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
5th Aug 202110:26 amGNWMan Group PLC : Form 8.3 - Bally's Corporation
4th Aug 20212:12 pmGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
4th Aug 20212:09 pmGNWMan Group PLC : Form 8.3 - Bally's Corporation
3rd Aug 202112:28 pmGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
3rd Aug 202112:25 pmGNWMan Group PLC : Form 8.3 - Bally's Corporation
2nd Aug 20211:42 pmGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.